Lead2030 Challenge for Goal 3

Supported by AstraZeneca

The Challenge: How do we fight the growing burden on non-communicable disease worldwide?

While many advances have been made to improve the health and wellbeing of vulnerable groups around the world, the targets laid out in SDG 3—for progress in reproductive, maternal, new-born and child health; infectious diseases; non-communicable diseases and mental health and health systems and funding—remain beyond our reach. 

Specific to SDG 3, we have focused our Lead2030 Challenge on SDG 3.4: to reduce premature mortality from non-communicable diseases (NCDs) by at least 33% through prevention and treatment and to promote mental health and well-being. NCDs have become the number one cause of morbidity and mortality worldwide, killing more than 41 million people each year. 

While they disproportionately impact people living in vulnerable situations, NCDs are an issue for everyone. Young people are most at risk, but they represent the greatest opportunity to change the trajectory of disease. Yet, young people are seldom present on the global health agenda. 

70% of premature deaths from NCDs can be traced to practices and habits that form in adolescence. Prevention is the most effective tool we have to fight the effects of NCDs. Through our Young Health Programme, we invest in education, advocacy and research to address the primary risk factors that lead to NCDs in later life.

The Lead2030 Challenge for SDG3, supported by AstraZeneca, has launched a global search for impactful youth-led initiatives working to tackle the growing burden on non-communicable diseases.

The Winner

Image removed.

Quinn Underwood, Advin


Reducing barriers to primary healthcare for vulnerable populations through digital health technology.


Using cutting-edge digital health technology ADVIN allows healthcare workers to monitor patient vital signs, screen for major communicable and non-communicable diseases, and communicate with physicians anywhere in real-time.

ADVIN’s approach to providing high-quality, low-cost primary care has two pillars:

  • Engagement: ADVIN works with trusted community partners of existing rural centres and infrastructure to run health literacy campaigns that disseminate information about health monitoring and digital health for rural populations.
  • Technology: ADVIN’s hardware, integrated with a proprietary AI-powered software platform, provides symptom and data-based diagnostic recommendations with pinpoint accuracy and efficiency. Health workers gather information through DNA samples (and other health devices) to input into the device, providing diagnostic recommendations and storing the information on database accessible to remote doctors.

This two-pronged approach allows healthcare workers to monitor vital signs and screen for the most major communicable and non-communicable diseases on-site, improving the quality of care and drastically reducing improper prescription of medication. ADVIN’s current model can perform 62 separate diagnostic tests, collecting the data necessary to diagnose over 300 diseases.

ADVIN’s focus on public health concerns like pregnancy-related diabetes, family planning, and maternal and child health has made them a vital provider for vulnerable women and children. ADVIN’s care has lent these at-risk populations a vital first step toward well-being and prosperity.

ADVIN have provided healthcare screening to more than 100,000 individuals across South Asia and are currently in the process of opening 1,000 primary health care centres (in partnership with the government of Bangladesh) to serve approximately 4.6 million people across Bangladesh.




“We speak of preventable diseases but have continually refused to take the action necessary in preventing them. This can go on no further.”